[Endothelial function in patients with arterial hypertension and impaired uric acid metabolism]. 2010

M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin

The aim of the study was to investigate endothelial function in patients with arterial hypertension and impaired uric acid metabolism in comparison with patients having arterial hypertension and normal uric acid metabolism. 46 patients aged 32-56 yr with grade I-II AH were included in the study. A group of 36 patients (27 male, 9 female) presented with AH and impaired uric acid metabolism (hyperuricemia), the control group included 10 patients with AH and unaffected uric acid metabolism. Inclusion criteria in the two groups were identical. Endothelial dysfunction was documented in all patients and confirmed by increased levels of serum endothelin-1 and microalbuminuria, qualitative and quantitative changes in the intima-media complex and its thickening. These changes were much more pronounced in patients with hyperuricemia It is concluded that impaired uric acid metabolism in patients with AH leads to rapid onset and progression of endothelial dysfunction. This fact should be taken into consideration by doctors practicing antihypertensive treatment and for the evaluation of cardiovascular risks.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000419 Albuminuria The presence of albumin in the urine, an indicator of KIDNEY DISEASES. Albuminurias
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin
January 1990, Pediatriia,
M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin
January 1974, Giornale di clinica medica,
M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin
January 2000, Medicina clinica,
M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin
December 1981, Revista clinica espanola,
M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin
January 1992, Pediatriia,
M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin
January 2008, Physiological research,
M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin
June 2003, Current hypertension reports,
M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin
October 1968, Coeur et medecine interne,
M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin
April 2000, Journal of hypertension,
M V Lebedeva, and T Iu Stakhova, and E G Minakova, and L I Zaĭtseva, and M M Severova, and A A Pulin
September 1991, Polskie Archiwum Medycyny Wewnetrznej,
Copied contents to your clipboard!